Mangrove Partners Teva Pharmaceutical Industries LTD Transaction History
Mangrove Partners
- $637 Million
- Q1 2025
A detailed history of Mangrove Partners transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Mangrove Partners holds 1,932,427 shares of TEVA stock, worth $32.1 Million. This represents 4.66% of its overall portfolio holdings.
Number of Shares
1,932,427
Previous 1,932,427
-0.0%
Holding current value
$32.1 Million
Previous $42.6 Million
30.26%
% of portfolio
4.66%
Previous 6.64%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
655Shares Held
655MCall Options Held
22MPut Options Held
15.8M-
Black Rock Inc. New York, NY43MShares$714 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$648 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$627 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$627 Million8.62% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.33.4MShares$554 Million6.4% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...